Release date: 23 December 2014
Promoter – Financial Intermediary
CHR. HANSEN HOLDING A/SLocation
Description
Financing of Christian Hansen A/S's RDI for the development of bioscience-based ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries.
Objectives
The project focuses on the research and development (R&D) activities of two of the promoter’s divisions with the most potential impact on health. It concerns the development of innovative solutions (i) to reduce sugar, salt and fat; and extend shelf life of food products for the Cultures & Enzymes division as well as (ii) to improve the stability of probiotic cultures, to protect agricultural crop or to explore bacterial applications to human health for the Health & Nutrition division.
The project will be implemented in the promoter’s existing R&D facilities in Denmark and France.
Sector(s)
Proposed EIB finance (Approximate amount)
EUR 75 million
Total cost (Approximate amount)
EUR 200 million
Environmental aspects
R&D activities included in the project will not materially change current practice and will be carried out within existing facilities and laboratories, pilot plants, etc. The R&D activities as such are not specifically listed in the Directive 2011/92/EU, therefore an Environmental Impact Assessment (EIA) should not be required by the competent authority. This, along with any other environmental details, will be verified during the appraisal.
Procurement
The promoter is a private company not operating in the utilities sector and not having a status of a contracting authority. Thus it is not covered by EU Directives on procurement.
Status
Signed - 11/12/2015
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).